Arbor Drug Patent Portfolio
Arbor owns 2 orange book drugs protected by 6 US patents Given below is the list of Arbor's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8747894 | Effervescent compositions containing N-acetylcysteine | 08 May, 2032 | Active |
| US9427421 | Effervescent compositions containing N-acetylcysteine | 08 May, 2032 | Active |
| US9561204 | Effervescent compositions containing N-acetylcysteine | 08 May, 2032 | Active |
| US8791153 | Topical avermectin formulations and methods for elimination and prophylaxis of susceptible and treatment-resistant strains of head lice | 12 Oct, 2027 | Active |
| US8927595 | Topical avermectin formulations and methods for elimination and prophylaxis of susceptible and treatment resistant strains of head lice | 12 Oct, 2027 | Active |
| US6103248 | Topical preparation and therapy for head lice | 22 May, 2018 | Expired |
Latest Legal Activities on Arbor's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Arbor.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Year, Large Entity | 31 Jan, 2022 | US8791153 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 31 Jul, 2020 | US9561204 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 29 Jan, 2018 | US8791153 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 07 Feb, 2017 | US9561204 |
|
Recordation of Patent Grant Mailed
Critical
| 07 Feb, 2017 | US9561204 |
|
Email Notification
Critical
| 04 Feb, 2017 | US9561204 |
| Mail-Petition Decision - Granted | 01 Feb, 2017 | US9561204 |
|
Petition Decision - Granted
Critical
| 31 Jan, 2017 | US9561204 |
|
Email Notification
Critical
| 19 Jan, 2017 | US9561204 |
|
Issue Notification Mailed
Critical
| 18 Jan, 2017 | US9561204 |
|
Application Is Considered Ready for Issue
Critical
| 29 Dec, 2016 | US9561204 |
| Dispatch to FDC | 29 Dec, 2016 | US9561204 |
|
Issue Fee Payment Received
Critical
| 21 Dec, 2016 | US9561204 |
|
Issue Fee Payment Verified
Critical
| 21 Dec, 2016 | US9561204 |
| Entity Status Set To Undiscounted (Initial Default Setting or Status Change) | 21 Nov, 2016 | US9561204 |
Arbor's Family Patents
Arbor Drug List
Given below is the complete list of Arbor's drugs and the patents protecting them.
1. Cetylev
Cetylev is protected by 3 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8747894 | Effervescent compositions containing N-acetylcysteine |
08 May, 2032
(6 years from now)
| Active |
| US9427421 | Effervescent compositions containing N-acetylcysteine |
08 May, 2032
(6 years from now)
| Active |
| US9561204 | Effervescent compositions containing N-acetylcysteine |
08 May, 2032
(6 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Cetylev's drug page
2. Sklice
Sklice is protected by 3 patents, out of which 1 has expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8791153 | Topical avermectin formulations and methods for elimination and prophylaxis of susceptible and treatment-resistant strains of head lice |
12 Oct, 2027
(1 year, 9 months from now)
| Active |
| US8927595 | Topical avermectin formulations and methods for elimination and prophylaxis of susceptible and treatment resistant strains of head lice |
12 Oct, 2027
(1 year, 9 months from now)
| Active |
| US6103248 | Topical preparation and therapy for head lice |
22 May, 2018
(7 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Sklice's drug page